Assessment of feasibility and efficacy of Class IV laser therapy for postoperative pain relief in off-pump coronary artery bypass surgery patients: A pilot study

Anil Karlekar, Saswata Bharati, Ravindra Saxena, Kanchan Mehta, Anil Karlekar, Saswata Bharati, Ravindra Saxena, Kanchan Mehta

Abstract

Background: Laser therapy, for its established analgesic properties with minimal side effects, has been used for the treatment of chronic pain. However, it has not been used for the treatment of acute postoperative pain. This pilot study was designed to assess the feasibility and efficacy of Class IV laser on postoperative pain relief following off-pump coronary artery bypass graft (OPCABG) surgery, as a component of multimodal analgesia (MMA) technique.

Methods: This open observational prospective study comprised of 100 adult patients (84 male, 16 female) who underwent OPCABG through sternotomy. For postoperative analgesia, they were subjected to laser therapy subjected to laser therapy in addition to the standard institutional pain management protocol comprising of IV infusion/bolus of tramadol and paracetamol and fentanyl bolus as rescue analgesic. Pain intensity was measured by Verbal Rating Scale (VRS). The laser therapy was scheduled as once a day regime for three consecutive postoperative days (PODs) starting on POD 1, 30 min following tracheal extubation. The subsequent laser applications were also scheduled at the same time of the day as on day 1 if VRS was ≥5. 10 W Class IV laser was applied over 150 cm² sternal wound area for 150 s. VRS was used to assess pain severity and was recorded for statistical analysis using Friedman Test.

Results: The mean (standard deviation [SD]) VRS of all the 100 patients just before application of the first dose of laser was 7.31 (0.94) while on MMT; the same fell to 4.0 (1.279) and 3.40 (2.697) at 1 h and 24 h respectively following first dose of laser. The change of VRS over first 24 h among all the 100 patients was statistically significant (P = 0.000). Laser was re-applied in 40 patients whose VRS was ≥5 (mean [SD] - 6.38 [0.868]) at 24th h. After receiving the 2nd dose of laser the VRS scores fell significantly (P = 0.000) and became 0 at 54th h. No patients required 3rd dose of the laser. No patient required rescue analgesic while on laser therapy.

Conclusion: Class IV laser can be an effective technique for postoperative analgesia following OPCABG surgery through sternotomy when included as a component of MMA technique.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Verbal Rating Scale (VRS) scores of patients receiving laser therapy. Series 1: Average VRS scores of all the 100 patients; Series 2: Average VRS scores of the 60 patients who received laser on postoperative day (POD) 1 only; Series 3: Average VRS scores of the 40 patients who received laser on POD 1 and POD 2

References

    1. Bigeleisen PE, Goehner N. Novel approaches in pain management in cardiac surgery. Curr Opin Anaesthesiol. 2015;28:89–94.
    1. Carr DB, Goudas LC. Acute pain. Lancet. 1999;353:2051–8.
    1. Chaney MA. Postoperative pain management for the cardiac patient. In: Kaplan JA, Reich DL, Savino JS, editors. Kaplan's Cardiac Anesthesia: The Eco Era. 6th ed. Saunders: Missouri; 2011. pp. 1107–37.
    1. Roberts DB, Kruse RJ, Stoll SF. The effectiveness of therapeutic class IV (10 W) laser treatment for epicondylitis. Lasers Surg Med. 2013;45:311–7.
    1. Panton L, Simonavice E, Williams K, Mojock C, Kim JS, Kingsley JD, et al. Effects of Class IV laser therapy on fibromyalgia impact and function in women with fibromyalgia. J Altern Complement Med. 2013;19:445–52.
    1. Ottaviani G, Gobbo M, Sturnega M, Martinelli V, Mano M, Zanconati F, et al. Effect of class IV laser therapy on chemotherapy-induced oral mucositis: A clinical and experimental study. Am J Pathol. 2013;183:1747–57.
    1. Zheng Z, Kang HY, Lee S, Kang SW, Goo B, Cho SB. Upregulation of fibroblast growth factor (FGF) 9 expression and FGF-WNT/β-catenin signaling in laser-induced wound healing. Wound Repair Regen. 2014;22:660–5.
    1. Basford JR, Sheffield CG, Mair SD, Ilstrup DM. Low-energy helium neon laser treatment of thumb osteoarthritis. Arch Phys Med Rehabil. 1987;68:794–7.
    1. Morimoto Y, Saito A, Tokuhashi Y. Low level laser therapy for sports injuries. Laser Ther. 2013;22:17–20.
    1. Bjordal JM, Lopes-Martins RA, Joensen J, Couppe C, Ljunggren AE, Stergioulas A, et al. A systematic review with procedural assessments and meta-analysis of low level laser therapy in lateral elbow tendinopathy (tennis elbow) BMC Musculoskelet Disord. 2008;9:75.
    1. Simunovic Z, Trobonjaca T, Trobonjaca Z. Treatment of medial and lateral epicondylitis – Tennis and golfer's elbow – With low level laser therapy: A multicenter double blind, placebo-controlled clinical study on 324 patients. J Clin Laser Med Surg. 1998;16:145–51.
    1. Bjordal JM, Couppé C, Chow RT, Tunér J, Ljunggren EA. A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust J Physiother. 2003;49:107–16.
    1. Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012;40:516–33.
    1. Avci P, Gupta A, Sadasivam M, Vecchio D, Pam Z, Pam N, et al. Low-level laser (light) therapy (LLLT) in skin: Stimulating, healing, restoring. Semin Cutan Med Surg. 2013:41–52.
    1. Piva JA, Abreu EM, Silva Vdos S, Nicolau RA. Effect of low-level laser therapy on the initial stages of tissue repair: Basic principles. An Bras Dermatol. 2011;86:947–54.
    1. Bjordal JM, Lopes-Martins RA, Iversen VV. A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations. Br J Sports Med. 2006;40:76–80.
    1. Colombo F, Neto Ade A, Sousa AP, Marchionni AM, Pinheiro AL, Reis SR. Effect of low-level laser therapy (λ660 nm) on angiogenesis in wound healing: A immunohistochemical study in a rodent model. Braz Dent J. 2013;24:308–12.
    1. dos Santos SA, Alves AC, Leal-Junior EC, Albertini R, Vieira Rde P, Ligeiro AP, et al. Comparative analysis of two low-level laser doses on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammation. Lasers Med Sci. 2014;29:1051–8.
    1. Moshkovska T, Mayberry J. It is time to test low level laser therapy in Great Britain. Postgrad Med J. 2005;81:436–41.
    1. Dixit S, Maiya A, Umakanth S, Borkar S. Photobiomodulation of surgical wound dehiscence in a diabetic individual by low-level laser therapy following median sternotomy. Indian J Palliat Care. 2013;19:71–5.

Source: PubMed

3
Abonnere